Aprepitant | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Aprepitant
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Aprepitant

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

47 API Suppliers, 17 USDMF, 11 CEP/COS, 4 JDMF, 9 EU WC, 9 KDMF, 15 NDC API, 33 Listed Suppliers, $ API Reference Price

47 API Suppliers
17 USDMF
11 CEP/COS
4 JDMF
9 EU WC
9 KDMF
15 NDC API
33 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

14 Drugs in Development

14 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

61 FDF Dossiers, 17 FDA Orange Book, 11 Europe, 4 Canada, 4 Australia, 9 South Africa, 16 Listed Dossiers

61 FDF Dossiers
17 FDA Orange Book
11 Europe
4 Canada
4 Australia
9 South Africa
16 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 15 SPI Pharma, 8 DKSH, 1 PMC Isochem, 3 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 4 Gangwal Healthcare, 2 Kewpie Corporation, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Pramukh Pharmachem, 4 ACG Worldwide, 1 Actylis, 1 Alcedo Pharmachem, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 1 Bioplus Life Sciences, 2 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 6 Kerry, 3 Lonza Capsugel, 5 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 13 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 Valens Pharmachem, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Fillers, Diluents & Binders, 22 Direct Compression, 22 Thickeners and Stabilizers, 17 Granulation, 15 Solubilizers, 15 Chewable & Orodispersible Aids, 15 Taste Masking, 14 Coating Systems & Additives, 12 Parenteral, 12 Disintegrants & Superdisintegrants, 11 Lubricants & Glidants, 11 Co-Processed Excipients, 9 Emulsifying Agents, 8 Topical, 8 Controlled & Modified Release, 8 Empty Capsules, 7 Film Formers & Plasticizers, 3 Coloring Agents, 1 Rheology Modifiers, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents

41 Fillers, Diluents & Binders
22 Direct Compression
22 Thickeners and Stabilizers
17 Granulation
15 Solubilizers
15 Chewable & Orodispersible Aids
15 Taste Masking
14 Coating Systems & Additives
12 Parenteral
12 Disintegrants & Superdisintegrants
11 Lubricants & Glidants
11 Co-Processed Excipients
9 Emulsifying Agents
8 Topical
8 Controlled & Modified Release
8 Empty Capsules
7 Film Formers & Plasticizers
3 Coloring Agents
1 Rheology Modifiers
1 API Stability Enhancers
1 Surfactant & Foaming Agents

DIGITAL CONTENT

15 NEWS #PharmaBuzz

15 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 8 Finished Drug Prices, 12 Annual Reports

1 US Medicaid Prescriptions
8 Finished Drug Prices
12 Annual Reports

MARKET PLACE

11 APIs, 2 FDF Dossiers

11 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

32 US Patents, 7 Health Canada Patents

32 US Patents
7 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 4 USP, 18 Others

1 EDQM
4 USP
18 Others

$ API Ref.Price (USD/KG) : 15,881 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

7 All

01 7Merck Canada Inc.

filter Patent Reset all filters

7 All

01 22178949

02 22293836

03 32469315

filter Product Reset all filters

7 All

01 7Aprepitant

filter Dosage Reset all filters

7 All

01 7Capsule

filter Exp Date Reset all filters

7 All

01 22014-12-13

02 22018-07-01

03 22022-12-09

04 12022-12-19

Product Main Page

01

Merck Canada Inc.

Aprepitant

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-12-19

Date Granted : 2008-12-02

Brand Name : EMEND

Patent Number : 2469315

Filing Date : 2002-12-09

Strength per Unit : 80mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-12-19

Date Granted : 2008-12-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Merck Canada Inc.

Aprepitant

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-12-09

Date Granted : 2002-12-02

Brand Name : EMEND

Patent Number : 2469315

Filing Date : 2002-12-09

Strength per Unit : 125mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-12-09

Date Granted : 2002-12-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Merck Canada Inc.

Aprepitant

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-12-09

Date Granted : 2008-12-02

Brand Name : EMEND

Patent Number : 2469315

Filing Date : 2002-12-09

Strength per Unit : Tri - pack: 80 mg and 125mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2022-12-09

Date Granted : 2008-12-02

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Merck Canada Inc.

Aprepitant

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-01

Date Granted : 2007-06-05

Brand Name : EMEND

Patent Number : 2293836

Filing Date : 1998-07-01

Strength per Unit : 80mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-01

Date Granted : 2007-06-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Merck Canada Inc.

Aprepitant

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-12-13

Date Granted : 2006-03-21

Brand Name : EMEND

Patent Number : 2178949

Filing Date : 1994-12-13

Strength per Unit : 80mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-12-13

Date Granted : 2006-03-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Merck Canada Inc.

Aprepitant

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-07-01

Date Granted : 2007-06-05

Brand Name : EMEND

Patent Number : 2293836

Filing Date : 1998-07-01

Strength per Unit : 125mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-07-01

Date Granted : 2007-06-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Merck Canada Inc.

Aprepitant

PharmScience R&D

Not Confirmed

Merck Canada Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-12-13

Date Granted : 2006-03-21

Brand Name : EMEND

Patent Number : 2178949

Filing Date : 1994-12-13

Strength per Unit : 125mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-12-13

Date Granted : 2006-03-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!